The Molecular Biology of Apolipoprotein B

  • J. Scott
Part of the Argenteuil Symposia book series (ARGENTEUIL)


An elevated level of circulating cholesterol is a most important risk factor for atherosclerosis. Cholesterol is carried in the plasma as low-density lipoprotein (LDL). LDL is an oily droplet, containing a core of hydrophobic cholesteryl esters and a surface monolayer of phospholipid and free cholesterol at the surface. The particle is stabilized and made soluble in the water of the blood by the presence at its surface of a huge protein apolipoprotein (apo) B (Scott 1989a).


Lipoprotein Particle Primer Extension Analysis Basic Peptide Thrombin Cleavage Site Lipoprotein Assembly 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Boström K, Lauer SJ, Poksay KS, Garcia Z, Taylor J, Innerarity TL (1989) Apolipoprotein B48 RNA editing in chimeric apolipoprotein EB mRNA. J Biol Chem 264:15701–15708PubMedGoogle Scholar
  2. Chen S-H, Habib G, Yang CY et al. (1987) Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 238:363–366PubMedCrossRefGoogle Scholar
  3. Collins DR, Knott TJ, Pease RJ et al. (1988) Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia. Nucl Acids Res 16:8361–8375PubMedCrossRefGoogle Scholar
  4. Davidson NO, Powell LM, Wallis SC, Scott J (1988) Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. J Biol Chem 263:13482–13485PubMedGoogle Scholar
  5. Davies MS, Wallis SC, Driscoll DM et al. (1989) Sequence requirements for apolipoprotein B RNA editing in transfected rat hepatoma cells. J Biol Chem 264:13395–13398PubMedGoogle Scholar
  6. Driscoll DM, Wynne JK, Wallis SC, Scott J (1989) An in vitro system for the editing of apolipoprotein B mRNA. Cell 58:519–525PubMedCrossRefGoogle Scholar
  7. Higuchi K, Hospattankar AV, Law SW, Meglin N, Cortright J, Brewer HB Jr (1988) Human apolipoprotein B (apoB) mRNA: identification of two distinct apoB mRNAs, an mRNA with the apoB-100 sequence and an apoB mRNA containing a premature in-frame translational stop codon, in both liver and intestine. Proc Natl Acad Sci USA 85:1772–1776PubMedCrossRefGoogle Scholar
  8. Hoeg JM, Meng MS, Ronan R, Demosky SJ Jr, Fairwell T, Brewer HB Jr (1988) Apolipoprotein B synthesized by Hep G2 cells undergoes fatty acid acylation. J Lipid Res 29:1215–1220PubMedGoogle Scholar
  9. Knott TJ, Pease RJ, Powell LM et al. (1986) Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature 323:734–738PubMedCrossRefGoogle Scholar
  10. Law A, Scott J (1990) A cross-species comparison of the apolipoprotein B domain that binds to the LDL receptor. J Lipid Res 31:1109–1120PubMedGoogle Scholar
  11. Milne R, Theolis R Jr, Maurice R et al. (1989) The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. J Biol Chem 264:19754–19760PubMedGoogle Scholar
  12. Pease RJ, Milne RW, Jessup WK et al. (1990) Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100. J Biol Chem 265:553–568PubMedGoogle Scholar
  13. Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J (1987) A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 50:831–840PubMedCrossRefGoogle Scholar
  14. Pullinger CR, North JD, Teng B-B, Rifici VA, de Brito AER, Scott J (1989) The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res 30:1065–1077PubMedGoogle Scholar
  15. Scott J (1989a) The molecular and cell biology of apolipoprotein-B. Mol Biol Med 6:65–80PubMedGoogle Scholar
  16. Scott J (1989b) Thrombogenesis linked to atherogenesis at last? Nature 341:22–23PubMedCrossRefGoogle Scholar
  17. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ (1989) Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci USA 86:587–591PubMedCrossRefGoogle Scholar
  18. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915–924PubMedCrossRefGoogle Scholar
  19. Talmud PJ, Lloyd JK, Muller DPR, Collins DR, Scott J, Humphries S (1988) Genetic evidence from two families that the apoliopoprotein B gene is not involved in abetalipoproteinemia. J Clin Invest 82:1803–1806PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 1992

Authors and Affiliations

  • J. Scott

There are no affiliations available

Personalised recommendations